CorMedix to Buy Heron Assets in Cash-and-Stock Deal
The proposed acquisition adds four commercial-stage products, with CorMedix expecting cost savings and a first-quarter 2027 closing.
Makkler Newsroom · Nov 9, 03:38 PM · 1 min read
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO